Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Accuray Precision Treatment Planning System

K-Number: K171086 · 2017-06-08

ApplicantAccuray Incorporated
Decision Date2017-06-08
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Accuray Precision Treatment Planning System is a medical device manufactured by Accuray Incorporated. It received FDA 510(k) clearance on 2017-06-08 under approval number K171086. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Accuray Precision Treatment Planning System?

Accuray Precision Treatment Planning System is a medical device that received FDA 510(k) clearance on 2017-06-08. It is manufactured by Accuray Incorporated. The 510(k) number is K171086.

When was Accuray Precision Treatment Planning System approved by the FDA?

Accuray Precision Treatment Planning System received FDA 510(k) clearance on 2017-06-08, under approval number K171086.

What company makes Accuray Precision Treatment Planning System?

Accuray Precision Treatment Planning System is manufactured by Accuray Incorporated.

What is the FDA product code for Accuray Precision Treatment Planning System?

The FDA product code for Accuray Precision Treatment Planning System is IYE.

Related Clinical Trials

NCT07614997 Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck NOT_YET_RECRUITING NCT05003843 BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis ACTIVE_NOT_RECRUITING NCT07499128 Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event ENROLLING_BY_INVITATION NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT05701917 DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis RECRUITING NCT07222787 Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes RECRUITING

Related PubMed Literature

PMID: 41915013 Few FDA Approved AI/ML Orthopaedic Devices Have EU MDR Equivalents or Peer-Reviewed Validation. Clinical orthopaedics and related research (2026) PMID: 41887630 Capacity building for ethical use of artificial intelligence in health: protocol for a scoping review of training initiatives and gaps in Africa. BMJ open (2026) PMID: 41533265 Modernizing Medical Software Regulation in Bangladesh: A Roadmap for Risk-Based SaMD Oversight. Journal of medical systems (2026) PMID: 41515650 Milestone to Ensure Safety and Efficacy of Companion Diagnostic (CDx) That Support Treatment Decisions in Cancer Patients. Diagnostics (Basel, Switzerland) (2026)

Other Devices by Accuray Incorporated

K161136Precision Treatment Planning System K161146Radixact Treatment Delivery System K161144iDMS Data Management System K171837TomoTherapy Treatment Delivery System with iDMS K182687Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System K202412ClearRT Helical kVCT for the Radixact Treatment Delivery System

View all 9 devices →

Related Devices (Code: IYE)

K162476Varian High Energy Linear AcceleratorVarian Medical Systems, Inc. K161400ImagingRing SystemMedphoton GmbH K162468ClearCheckRadformation K162355Raycast MammoRx Carbon Fibre Breast BoardOrfit Industries NV K162577Dosimetry Check Version 5 Release 1Math Resolutions, LLC K162265CushionCast Moldable CushionsIzi Medical Products, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑